Symdeko
Symdeko Indication Broadened to Include CF Patients as Young as 6
The FDA approved the use of tezacaftor-ivacaftor (Symdeko, Vertex) for the treatment of pediatric patients aged 6 ...
JUNE 25, 2019
FDA Approves Symdeko for CF Patients
Symdeko by Vertex is indicated for people with two copies of the F508del mutation in the CFTR gene or who have at ...
FEBRUARY 13, 2018
Load more